$282 Million is the total value of DCF Advisers, LLC's 93 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UVXY | Exit | PROSHARES TR IIultra vix short | $0 | – | -13,250 | -100.0% | -0.03% | – |
| VBIV | Exit | VBI VACCINES INC CDA | $0 | – | -26,000 | -100.0% | -0.04% | – |
| ADT | Exit | ADT INC DEL | $0 | – | -14,000 | -100.0% | -0.05% | – |
| UVXY | Exit | PROSHARES TR IIcall | $0 | – | -36,500 | -100.0% | -0.09% | – |
| TBT | Exit | PROSHARES TR | $0 | – | -9,500 | -100.0% | -0.09% | – |
| NVDA | Exit | NVIDIA CORPORATIONcall | $0 | – | -400 | -100.0% | -0.09% | – |
| F | Exit | FORD MTR CO DELcall | $0 | – | -20,000 | -100.0% | -0.11% | – |
| CRM | Exit | SALESFORCE COM INC | $0 | – | -1,250 | -100.0% | -0.12% | – |
| BOX | Exit | BOX INCcall | $0 | – | -12,500 | -100.0% | -0.12% | – |
| TDC | Exit | TERADATA CORP DEL | $0 | – | -7,500 | -100.0% | -0.13% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -5,000 | -100.0% | -0.14% | – |
| FXI | Exit | ISHARES TRcall | $0 | – | -8,000 | -100.0% | -0.16% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -17,286 | -100.0% | -0.21% | – |
| NVDA | Exit | NVIDIA CORPORATION | $0 | – | -1,000 | -100.0% | -0.23% | – |
| SPCE | Exit | VIRGIN GALACTIC HOLDINGS INC | $0 | – | -18,500 | -100.0% | -0.25% | – |
| AMD | Exit | ADVANCED MICRO DEVICES INCcall | $0 | – | -7,500 | -100.0% | -0.26% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -17,125 | -100.0% | -0.26% | – |
| BDX | Exit | BECTON DICKINSON & COcall | $0 | – | -2,500 | -100.0% | -0.26% | – |
| GILD | Exit | GILEAD SCIENCES INCput | $0 | – | -10,000 | -100.0% | -0.28% | – |
| VZ | Exit | VERIZON COMMUNICATIONS INCcall | $0 | – | -12,500 | -100.0% | -0.32% | – |
| IBB | Exit | ISHARES TRcall | $0 | – | -5,000 | -100.0% | -0.33% | – |
| ABBV | Exit | ABBVIE INCcall | $0 | – | -7,500 | -100.0% | -0.35% | – |
| TGT | Exit | TARGET CORP | $0 | – | -5,000 | -100.0% | -0.43% | – |
| PG | Exit | PROCTER AND GAMBLE COput | $0 | – | -7,500 | -100.0% | -0.44% | – |
| LOW | Exit | LOWES COS INC | $0 | – | -7,500 | -100.0% | -0.62% | – |
| FMS | Exit | FRESENIUS MED CARE AG&CO KGAsponsored adr | $0 | – | -43,400 | -100.0% | -0.70% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -21,500 | -100.0% | -0.70% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -5,000 | -100.0% | -0.86% | – |
| IAU | Exit | ISHARES GOLD TRishares | $0 | – | -200,000 | -100.0% | -1.41% | – |
| IBB | Exit | ISHARES TRput | $0 | – | -35,000 | -100.0% | -2.29% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -23,000 | -100.0% | -3.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
| MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
| ALPHABET INC | 16 | Q3 2023 | 5.8% |
| ABBVIE INC | 16 | Q3 2023 | 7.9% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
| ARGENX SE | 16 | Q3 2023 | 6.4% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
| XENCOR INC | 16 | Q3 2023 | 4.1% |
| BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
| ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.